Ameriprise’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $253K | Sell |
50,014
-43,925
| -47% | -$222K | ﹤0.01% | 3725 |
|
|
2025
Q1 | $497K | Buy |
93,939
+2,269
| +2% | +$12K | ﹤0.01% | 3454 |
|
|
2024
Q4 | $620K | Buy |
91,670
+29,034
| +46% | +$196K | ﹤0.01% | 3415 |
|
|
2024
Q3 | $413K | Sell |
62,636
-6,497
| -9% | -$42.8K | ﹤0.01% | 3540 |
|
|
2024
Q2 | $518K | Sell |
69,133
-11,481
| -14% | -$86.1K | ﹤0.01% | 3403 |
|
|
2024
Q1 | $804K | Buy |
80,614
+40,103
| +99% | +$400K | ﹤0.01% | 3259 |
|
|
2023
Q4 | $399K | Buy |
+40,511
| New | +$399K | ﹤0.01% | 3529 |
|